Stay updated with breaking news from Jamesb Bussel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Several hematologists will be honored during this year’s ASH Annual Meeting, scheduled for Dec. 9-12 in San Diego.ASH’s honorific awards recognize clinicians and scientists who have made important contributions to the field.
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center.
Responses in 80%, sustained in 61% with all-trans retinoic acid and low-dose rituximab